netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.04  Expand sub section  CNS stimulants and other drugs used for attention deficit hyperactivity disorder
 note 

Shared care documents from Black Country Partnership NHS FT can be accessed from this here

Atomoxetine (Strattera ®)
View adult BNF View SPC online View childrens BNF
Formulary

Please note that commissioning discussion is underway. However the present status is as follows:-

Birmingham and Solihull CCG
 
 Age 6 and over - Solihull practices.  Supported with ESCA

 Age 16 and over - Birmingham practices.  Supported with ESCA

 Age under 16 - Birmingham practices

Sandwell and West Birmingham CCG

 Age 6 and over. Supported with ESCA.  Click here for shared care document for patients seen by Black Country Partnership NHS FT 

 
Link  ESCA: Atomoxetine
Link  Shared care documents from Black Country Partnership NHS FT can be accessed here
   
Controlled Drug Dexamfetamine
View adult BNF View SPC online View childrens BNF
Formulary

Please note that commissioning discussion is underway. However the present status is as follows:-

Birmingham and Solihull CCG
 
 Age 6 and over - Solihull practices.  Supported with ESCA

 Age 16 and over - Birmingham practices.  Supported with ESCA

 Age under 16 - Birmingham practices

Sandwell and West Birmingham CCG

 Age 6 and over. Supported with ESCA.  Click here for shared care document for patients seen by Black Country Partnership NHS FT 

 
Link  ESCA: Dexamfetamine as Amfexa
Link  Shared care documents from Black Country Partnership NHS FT can be accessed here
   
Guanfacine (Intuniv®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
for the treatment of ADHD in children and adolescents 6-17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.  
   
Lisdexamfetamine
(Elvanse®)
View adult BNF View SPC online View childrens BNF
Formulary

Please note that commissioning discussion is underway. However the present status is as follows:-

Birmingham and Solihull CCG
 
 Age 6 and over - Solihull practices.  Supported with ESCA

 Age 16 and over - Birmingham practices.  Supported with ESCA

 Age under 16 - Birmingham practices

Sandwell and West Birmingham CCG

 Age 6 and over. Supported with ESCA.  Click here for shared care document for patients seen by Black Country Partnership NHS FT 

 
Link  ESCA: Lisdexamfetamine
Link  Shared care documents from Black Country Partnership NHS FT can be accessed here
   
Controlled Drug Methylphenidate Modified-Release (tablets/capsules)
View adult BNF View SPC online View childrens BNF
Formulary

Please note that commissioning discussion is underway. However the present status is as follows:-

Birmingham and Solihull CCG
 
 Age 6 and over - Solihull practices.  Supported with ESCA

 Age 16 and over - Birmingham practices.  Supported with ESCA

 Age under 16 - Birmingham practices

Sandwell and West Birmingham CCG

 Age 6 and over. Supported with ESCA.  Click here for shared care document for patients seen by Black Country Partnership NHS FT 

 
Link  ESCA: Methylphenidate
Link  Shared care documents from Black Country Partnership NHS FT can be accessed here
Link  Medicines Q&A: Methylphenidate for adults with ADHD
   
Controlled Drug Methylphenidate tablets
View adult BNF View SPC online View childrens BNF
Formulary

Please note that commissioning discussion is underway. However the present status is as follows:-

Birmingham and Solihull CCG
 
 Age 6 and over - Solihull practices.  Supported with ESCA

 Age 16 and over - Birmingham practices.  Supported with ESCA

 Age under 16 - Birmingham practices

Sandwell and West Birmingham CCG

 Age 6 and over. Supported with ESCA.  Click here for shared care document for patients seen by Black Country Partnership NHS FT 

 
Link  ESCA: Methylphenidate
Link  Shared care documents from Black Country Partnership NHS FT can be accessed here
Link  Medicines Q&A: Methylphenidate for adults with ADHD
   
Modafinil
View adult BNF View SPC online View childrens BNF
Formulary
Amber Recommended
  • for narcolepsy
 
   
04.04  Expand sub section  Cocaine
 ....
 Non Formulary Items
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Prescribing in children

The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.
  

Green

Medicines suitable for routine use within primary care. Initiation and maintenance of prescribing by Specialists, GPs and other qualified clinicians.   

Amber Initiation

Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.  

Amber Recommended

Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.  

Amber SC

Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry.  

Red

Medicines for initiation and maintenance prescribing by Specialists only.  

Black

Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use.  

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information.  

The term 'Specialist' refers to Consultants, General Practitioners and Independant Prescribers with a Specialist Interest.  

netFormulary